Related Experiment Video
Updated: Jul 25, 2026
07:45
An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Creutzfeldt-Jakob disease.
1Department of Neurology, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry.
The Journal of the Association of Physicians of India
|December 13, 2005
Summary
Creutzfeldt-Jakob disease is a rare, fatal prion disease affecting the brain. Advances in diagnostics and treatments present new challenges in controlling this transmissible neurodegenerative condition.
Area of Science:
- Neurology
- Prion Diseases
- Neurodegenerative Disorders
Background:
- Creutzfeldt-Jakob disease (CJD) is a fatal, transmissible prion disease causing spongiform encephalopathy.
- The discovery of CJD's pathogenesis by Pruisner in 1982 and the emergence of variant CJD ('mad cow disease') heightened scientific and clinical interest.
- Sporadic genetic variants of CJD remain a significant challenge for geneticists.
Purpose of the Study:
- To review the distinct clinical features and novel transmission mechanisms of Creutzfeldt-Jakob disease.
- To discuss the impact of variant CJD on food safety regulations.
- To highlight diagnostic advancements and challenges in managing CJD, particularly concerning cadaver-derived therapeutic products.
Main Methods:
- Review of scientific literature on prion diseases and Creutzfeldt-Jakob disease.
- Analysis of diagnostic advancements including neuroimaging, cerebrospinal fluid markers, and genetic studies.
- Examination of challenges posed by therapeutic products derived from cadaveric sources.
Main Results:
- Neuroimaging, CSF markers, and genetic studies offer improved diagnostic capabilities for CJD.
- The use of cadaver-derived products (e.g., growth hormone, grafts) introduces new challenges in disease control.
- Understanding CJD pathogenesis and transmission is crucial for public health and clinical management.
Conclusions:
- Creutzfeldt-Jakob disease, a rare prion disorder, presents unique diagnostic and management challenges.
- Continued research into sporadic genetic variants and control of iatrogenic transmission is essential.
- Advances in diagnostics aid in identifying CJD, but controlling its spread, especially via medical interventions, requires ongoing vigilance.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...